Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
HCV - GOING TO DOMINATE!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5071101"]The national meetings haven't discussed any details. Merck only cares about sharing details with Managers the reps hear things from doctors that deal with other hidden people at Merck. Merck's problem is the communication is so random that people don't have trust or value in conference calls and meetings because noone higher up finds value in being transparent and honest with the salesforce. Unlike other companies, when information is released they openly send emails, have calls with everyone and the customers are informed with most of the same information quickly. Merck hides behind their lawyers and delays reports, sales aids, customer questions and needs are ignored and the medical responses are a joke. The real reason people are waiting is for the patients with insurance issues and the patients who are F1/2. Noone should think that ANY of the HCV drugs will be used 100%. Any doctors that doesn't find value in looking at all the new combinations is probably a speaker or part of a study and tainted. The majority of institutions and community MD's will use all of the new drugs and start nitching groups with certain drugs based on real life data. The drug approvals are being allowed FDA approvals with low number patients in studies which could very well change in the real world when doctors treat over 10-20 people with complicatoion- cirrhosis, geno 1a or 1b, F3/4, diabetes, coinfections,heart disease, race gender issues, weight, compliance etc Real life will determine the success of these new drugs. Insurance could mandate what people prescribe.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5071101"]The national meetings haven't discussed any details. Merck only cares about sharing details with Managers the reps hear things from doctors that deal with other hidden people at Merck. Merck's problem is the communication is so random that people don't have trust or value in conference calls and meetings because noone higher up finds value in being transparent and honest with the salesforce. Unlike other companies, when information is released they openly send emails, have calls with everyone and the customers are informed with most of the same information quickly. Merck hides behind their lawyers and delays reports, sales aids, customer questions and needs are ignored and the medical responses are a joke. The real reason people are waiting is for the patients with insurance issues and the patients who are F1/2. Noone should think that ANY of the HCV drugs will be used 100%. Any doctors that doesn't find value in looking at all the new combinations is probably a speaker or part of a study and tainted. The majority of institutions and community MD's will use all of the new drugs and start nitching groups with certain drugs based on real life data. The drug approvals are being allowed FDA approvals with low number patients in studies which could very well change in the real world when doctors treat over 10-20 people with complicatoion- cirrhosis, geno 1a or 1b, F3/4, diabetes, coinfections,heart disease, race gender issues, weight, compliance etc Real life will determine the success of these new drugs. Insurance could mandate what people prescribe.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
HCV - GOING TO DOMINATE!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
HCV - GOING TO DOMINATE!
>